Paediatric steatotic liver disease has unique characteristics: A multisociety statement endorsing the new nomenclature
Authors:
- Hepatology And Nutrition (Espghan) European Society For Pediatric GastroenterologyHGHepatology And Nutrition (Espghan) European Society For Pediatric Gastroenterology
- European Association for the Study of the Liver (EASL)E(European Association for the Study of the Liver (EASL)
- Hepatology North American Society For Pediatric GastroenterologyHGHepatology North American Society For Pediatric Gastroenterology
- Hepatology Latin‐American Society For Pediatric GastroenterologyHGHepatology Latin‐American Society For Pediatric Gastroenterology
- Hepatology And Nutrition (Appspghan) Asian Pan‐Pacific Society For Pediatric GastroenterologyHGHepatology And Nutrition (Appspghan) Asian Pan‐Pacific Society For Pediatric Gastroenterology
- Pan Arab Society For Pediatric Gastroenterology And Nutrition (Paspghan)P(Pan Arab Society For Pediatric Gastroenterology And Nutrition (Paspghan)
- Commonwealth Association of Paediatric Gastroenterology & Nutrition (CAPGAN)C(Commonwealth Association of Paediatric Gastroenterology & Nutrition (CAPGAN)
Open Access
- 26 March 2024
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 78 (5) , 1190-1196
Abstract
Nonalcoholic fatty liver disease (NAFLD) has been a commonly used term and diagnosis in paediatric hepatology, gastroenterology, and endocrinology clinics for over 30 years. A multisociety Delphi process has determined a new name “Steatotic Liver Disease” (SLD) as the overarching term for disorders associated with hepatic lipid accumulation. Our Societies give our support to steatotic liver disease as the best overarching term for use in our communities. Metabolic dysfunction‐associated steatotic liver disease (MASLD) overcomes many of the shortcomings of the name NAFLD. Here, we highlight several points of the new nomenclature that are of particular importance for our community and their consequences for implementation including: diagnostic criteria, considering alternate diagnoses, practical implementation, research, advocacy, and education for paediatricians. As with all nomenclature changes, it will take a concerted effort from our paediatric societies to help integrate the optimal use of this into practice.Keywords
This publication has 25 references indexed in Scilit:
- Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertaintiesJournal of Hepatology, 2023
- American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical SettingsEndocrine Practice, 2022
- Impact of the new definition of metabolic dysfunction–associated fatty liver disease on detection of significant liver fibrosis in US adolescentsHepatology Communications, 2022
- Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statementThe Lancet Gastroenterology & Hepatology, 2021
- The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in ChinaHepatobiliary & Pancreatic Diseases International, 2021
- Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysisEuropean Radiology, 2019
- Paediatric fatty liver disease (PeFLD): All is not NAFLD – Pathophysiological insights and approach to managementJournal of Hepatology, 2018
- Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver diseaseHepatology, 2015
- The metabolic syndromeThe Lancet, 2010
- Metabolic Syndrome and Risk of Cardiovascular Disease: A Meta-AnalysisThe American Journal of Medicine, 2006